Clinical Trial Update: Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)

View source ↗

Summary

This is a real-world evidence update on benralizumab for severe eosinophilic asthma in Russia (BEST), based on a completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Eosinophilic Asthma | Status: COMPLETED